Increases amount of cigarette and other tobacco products tax revenues provided to New Jersey Commission on Cancer Research from $1 million to $4 million; establishes dedicated, non-lapsing Cancer Research Fund.

S 2389 increases annual funding for New Jersey's Commission on Cancer Research from $1 million to $4 million by redirecting tobacco tax revenues into a dedicated Cancer Research Fund. This replaces the previous lapsing fund that had been diverted to the General Fund, ensuring the $4 million is permanently available for cancer research. The new non-lapsing fund, managed by the State Treasurer, will exclusively provide grants for research projects approved by the Commission, with interest earned also funding the cause. This change guarantees stable, long-term support for the Commission's work on cancer prevention, treatment, and research in New Jersey.